Table 1.
Summary of the in vivo activity of the enhancer
| Construct | TG | ES | ET | NO |
|---|---|---|---|---|
| HHXK | 14 | 9 | 2 | 5 |
| tkXK | 13 | 6 | 0 | 7 |
| KXtk | 12 | 7 | 2 | 5 |
| tkNcXb | 15 | 9 | 8 | 5 |
| tk- | 9 | 0 | 1 | 8 |
Abbreviations are as in Fig. 1. Data are presented as numbers of embryos.
Summary of the in vivo activity of the enhancer
| Construct | TG | ES | ET | NO |
|---|---|---|---|---|
| HHXK | 14 | 9 | 2 | 5 |
| tkXK | 13 | 6 | 0 | 7 |
| KXtk | 12 | 7 | 2 | 5 |
| tkNcXb | 15 | 9 | 8 | 5 |
| tk- | 9 | 0 | 1 | 8 |
Abbreviations are as in Fig. 1. Data are presented as numbers of embryos.